Evidence map›Paper›PMID 42634803›Full record

ArticleCureus2026

Delayed Diagnosis of Common Variable Immunodeficiency Revealed by Recurrent Respiratory Infections and Persistent Mediastinal Lymphadenopathy: A Case Report.

Mohammed Aharmim, Mohamed Lakhal, Nezha Reguig, Loudiyi Sara, Jamal Eddine Bourkadi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammed AharmimPulmonology and Phthisiology, Moulay Youssef Hospital, Rabat, MAR.
Mohamed LakhalRespiratory Diseases, Faculty of Medicine and Pharmacy, Centre Hospitalier Universitaire (CHU) Mohammed VI, Mohammed I University, Oujda, MAR.
Nezha ReguigPulmonology, Faculty of Medicine and Pharmacy, Moulay Youssef Hospital, Mohammed V University, Rabat, MAR.
Loudiyi SaraPulmonology, Moulay Youssef Hospital, Centre Hospitalo Universitaire (CHU) Ibn Sina, Rabat, MAR.
Jamal Eddine BourkadiPulmonology, Moulay Youssef Hospital, Rabat, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency in adults and is characterized by impaired antibody production, hypogammaglobulinemia, and recurrent infections. Owing to its marked clinical heterogeneity, the diagnosis is frequently delayed, particularly in patients presenting with atypical manifestations. We report the case of a 57-year-old woman who presented with recurrent lower respiratory tract infections associated with persistent mediastinal lymphadenopathy. Initial chest computed tomography revealed a right-sided pneumonic consolidation with centrilobular tree-in-bud micronodules. Follow-up imaging demonstrated complete resolution of the pulmonary micronodules but persistent mediastinal lymphadenopathy, prompting extensive investigations. Histopathological examination of an axillary lymph node showed reactive follicular hyperplasia, while microbiological investigations, including Xpert MTB/RIF and bronchoalveolar lavage cultures, were negative. Further evaluation excluded sarcoidosis, hematological malignancy, and other infectious causes. Serum protein electrophoresis revealed marked hypogammaglobulinemia, and quantitative immunoglobulin testing demonstrated markedly decreased serum IgG (0.98 g/L; reference range: 7-16 g/L) and complete IgA deficiency (0 g/L; reference range: 0.7-4.0 g/L), establishing the diagnosis of CVID. This case highlights the diagnostic challenge posed by late-presenting CVID and emphasizes that recurrent respiratory infections associated with persistent lymphadenopathy should prompt consideration of an underlying primary immunodeficiency, even in older adults. Early recognition and timely initiation of immunoglobulin replacement therapy are essential to prevent irreversible pulmonary complications and improve long-term outcomes.

Indexed as

common variable immunodeficiencyhypogammaglobulinemiaiatrogenic hypogammaglobulinemiamediastinal lymphadenopathyprimary immunodeficiency

Identifiers

PMID42634803
PMCPMC13500081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.